Yamamoto Junkoh, Kitagawa Takehiro, Miyaoka Ryo, Suzuki Kohei, Takamatsu Seishiro, Saito Takeshi, Nakano Yoshiteru
Department of Neurosurgery, University of Occupational and Environmental Health, Japan.
J UOEH. 2020;42(1):27-34. doi: 10.7888/juoeh.42.27.
5-Aminolevulinic acid (ALA) has been widely used as an intravital fluorescence marker in the fluorescence-guided resection of malignant gliomas. Although not a photosensitizer itself, 5-ALA is a prodrug that accumulates protoporphyrin IX (PpIX) in the mitochondria of glioma cells; PpIX acts as a photosensitizer. Fluorescence-guided resection for malignant gliomas has some pitfalls. Moreover, 5-ALA is not merely a fluorescence marker but has potential as a mitochondria-targeting drug for malignant glioma therapy. In this article, we review the literature related to 5-ALA, discuss the pitfalls of fluorescence-guided resection using 5-ALA for malignant gliomas, and describe the application of 5-ALA for malignant glioma therapy with personal opinions.
5-氨基乙酰丙酸(ALA)已被广泛用作恶性胶质瘤荧光引导切除术中的活体荧光标记物。尽管5-ALA本身不是光敏剂,但它是一种前药,可在胶质瘤细胞的线粒体中积累原卟啉IX(PpIX);PpIX充当光敏剂。恶性胶质瘤的荧光引导切除存在一些缺陷。此外,5-ALA不仅是一种荧光标记物,还具有作为恶性胶质瘤治疗的线粒体靶向药物的潜力。在本文中,我们回顾了与5-ALA相关的文献,讨论了使用5-ALA进行恶性胶质瘤荧光引导切除的缺陷,并阐述了5-ALA在恶性胶质瘤治疗中的应用及个人观点。